Equities

Bafna Pharmaceuticals Ltd

BAFNAPH:NSI

Bafna Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)77.08
  • Today's Change-1.92 / -2.43%
  • Shares traded4.88k
  • 1 Year change-12.36%
  • Beta1.3394
Data delayed at least 15 minutes, as of Sep 20 2024 10:57 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue1,5261,154851
OPERATING EXPENSES
Cost of revenue total1,029766513
Selling, general and admin. expenses, total280159146
Depreciation/amortization505355
Unusual expense(income)0022
Other operating expenses, total965772
Total operating expense1,4541,035808
Operating income7111943
Other, net2.98(2.4)17
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes7311652
Provision for income taxes02.780
Net income after taxes7311352
Minority interest------
Net income before extra. Items7311352
Total extraordinary items------
Net income7311352
Inc.avail. to common excl. extra. Items7311352
Inc.avail. to common incl. extra. Items7311352
EPS RECONCILIATION
Basic/primary weighted average shares242324
Basic/primary eps excl. extra items3.114.862.19
Basic/primary eps incl. extra items3.114.862.19
Dilution adjustment------
Diluted weighted average shares242324
Diluted eps excl. extra items3.114.862.19
Diluted eps incl. extra items3.114.862.19
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock00--
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental1918--
SUPPLEMENTAL INCOME
Depreciation, supplemental505355
Total special items(0.66)(1.96)22
NORMALISED INCOME
Normalized income before taxes7311474
Effect of special items on income taxes0(0.05)0
Income tax excluding impact of special items02.740
Normalized income after tax7311174
Normalized income avail. to common7311174
Basic normalized EPS3.084.783.10
Diluted normalized EPS3.084.783.10
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.